| scholarly article | Q13442814 |
| P50 | author | James F. Rusling | Q87910675 |
| John B. Schenkman | Q130239629 | ||
| Ingela Jansson | Q130239688 | ||
| P2093 | author name string | Besnik Bajrami | |
| Dominic O Hull | |||
| P2860 | cites work | L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities | Q24528320 |
| Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data | Q28367250 | ||
| THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES | Q29616219 | ||
| The determination of enzyme inhibitor constants | Q29618526 | ||
| Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant | Q31012256 | ||
| In vitro cytochrome P450 inhibition data and the prediction of drug-drug interactions: qualitative relationships, quantitative predictions, and the rank-order approach | Q31024427 | ||
| Computer-assisted design of selective imidazole inhibitors for cytochrome p450 enzymes | Q31081174 | ||
| Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain | Q33571387 | ||
| The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions | Q35768482 | ||
| Sensors for toxicity of chemicals and oxidative stress based on electrochemical catalytic DNA oxidation | Q35941870 | ||
| Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs | Q36094600 | ||
| Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism | Q36097229 | ||
| Enzyme kinetics for clinically relevant CYP inhibition | Q36173116 | ||
| Microsome biocolloids for rapid drug metabolism and inhibition assessment by LC-MS | Q36323058 | ||
| Biochemical applications of ultrathin films of enzymes, polyions and DNA. | Q36323070 | ||
| Synergistic metabolic toxicity screening using microsome/DNA electrochemiluminescent arrays and nanoreactors | Q36355156 | ||
| Electrochemiluminescent/voltammetric toxicity screening sensor using enzyme-generated DNA damage | Q36571450 | ||
| Electrochemiluminescent arrays for cytochrome P450-activated genotoxicity screening. DNA damage from benzo[a]pyrene metabolites | Q36571491 | ||
| Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment | Q36985086 | ||
| Antiarrhythmics: elimination and dosage considerations in hepatic impairment | Q37008809 | ||
| Electrochemical biosensor featuring a two-enzyme pathway and DNA for screening toxic reactive metabolites of arylamines | Q37026167 | ||
| Pharmacokinetics and metabolic drug interactions. | Q37230205 | ||
| Relationship of active site topology to substrate specificity for cytochrome P450terp (CYP108). | Q42695535 | ||
| Detection of chemically induced DNA damage in layered films by catalytic square wave voltammetry using Ru(bpy)3(2+). | Q43780155 | ||
| Optimization of electrochemical and peroxide-driven oxidation of styrene with ultrathin polyion films containing cytochrome P450cam and myoglobin | Q44269296 | ||
| Toxicity screening by electrochemical detection of DNA damage by metabolites generated in situ in ultrathin DNA-enzyme films | Q44294069 | ||
| Simultaneous direct electrochemiluminescence and catalytic voltammetry detection of DNA in ultrathin films. | Q44412560 | ||
| Epoxidation of styrene by human cyt P450 1A2 by thin film electrolysis and peroxide activation compared to solution reactions | Q44497200 | ||
| Direct electrochemiluminescence detection of oxidized DNA in ultrathin films containing [Os(bpy)2(PVP)10]2+. | Q44975981 | ||
| Steric factors in the inhibitory interaction of imidazoles with microsomal enzymes | Q45082457 | ||
| Characterization of structural xenobiotic modifications in proteins by high sensitivity tandem mass spectrometry. Human hemoglobin treated in vitro with styrene 7,8-oxide. | Q45991404 | ||
| Cytochrome P450 active site plasticity: attenuation of imidazole binding in cytochrome P450(cam) by an L244A mutation. | Q46322326 | ||
| Quantitative measurement of DNA adducts using neutral hydrolysis and LC-MS. Validation of genotoxicity sensors | Q46413895 | ||
| Enzyme-DNA biocolloids for DNA adduct and reactive metabolite detection by chromatography-mass spectrometry | Q46793138 | ||
| Imidazole derivatives as antioxidants and selective inhibitors of nNOS. | Q46794378 | ||
| Electrochemical genotoxicity screening for arylamines bioactivated by N-acetyltransferase | Q46812420 | ||
| Enzyme-like kinetics of ferryloxy myoglobin formation in films on electrodes in microemulsions | Q46866204 | ||
| Genotoxicity screening using biocatalyst/DNA films and capillary LC-MS/MS. | Q46891796 | ||
| Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods? | Q46906656 | ||
| Use of isolated hepatocyte preparations for cytochrome P450 inhibition studies: comparison with microsomes for Ki determination | Q48569653 | ||
| Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is common. | Q50707831 | ||
| Kinetics of metabolite formation and elimination in the perfused rat liver preparation: differences between the elimination of preformed acetaminophen and acetaminophen formed from phenacetin | Q67394645 | ||
| The catalytic activity of cytochrome P450cam towards styrene oxidation is increased by site-specific mutagenesis | Q73194339 | ||
| Drug-induced changes in P450 enzyme expression at the gene expression level: a new dimension to the analysis of drug-drug interactions | Q79374421 | ||
| Genotoxicity screening for N-nitroso compounds. Electrochemical and electrochemiluminescent detection of human enzyme-generated DNA damage from N-nitrosopyrrolidine | Q80212640 | ||
| Comparative 1-substituted imidazole inhibition of cytochrome p450 isozyme-selective activities in human and mouse hepatic microsomes | Q81041579 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | electrochemistry | Q7877 |
| P304 | page(s) | 716-724 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Analytical Chemistry | Q485223 |
| P1476 | title | Characterizing metabolic inhibition using electrochemical enzyme/DNA biosensors | |
| P478 | volume | 81 |
Search more.